HK1182934B - Anti-fatigue composition, formulation and use thereof - Google Patents

Abstract

An anti-fatigue composition consisting of 20(S)-protopanoxadiol and lycium barbarum polysaccharide. Experiments prove that the composition exhibits a significant anti-fatigue effect. In comparison with the effect attained by the single use of lycium barbarum polysaccharide or 20(S)-protopanoxadiol, the combined use of 20(S)-protopanoxadiol and lycium barbarum polysaccharide exerts an obvious synergistic effect.

Description

Technical Field

The present invention belongs to medicine field, particularly relates to an anti-fatigue composition, formulation and use thereof.

Background Art

At the fifth International Biochemistry of Exercise Congress in 1982, the fatigue is defined that: the body's physiological processes can not maintain its function at a certain degree or the organs can not maintain its predetermined exercise intensity.

Fatigue is classified as central nervous system fatigue, nerve-muscle joint fatigue and peripheral fatigue of the limbs. Fatigue is a comprehensive physiological process involving many physiological and biochemical factors, and it's a normal physiological phenomenon inevitably occurring at a certain stage of the mental activity or physical activity of the body. It marks a temporary decline of the original work ability of the body, and may be an indication indicating the body develops to an injury status.

At present people are paying more attention to the Chronic Fatigue Syndrome (CFS). CFS is a group of syndrome, which takes long-term durable fatigue as prominent manifestation, accompanying with non-specific manifestations of low fever, headache, sore throat, muscle and joint pain, inattention, memory decline, sleep disorders, depression and the like, generally nothing abnormal is detected in physical examination and routine examination (Holmes GO, Kaplan JE, Gantz NM, et al. Chronic Fatigue Syndrome: A Working Case Difinition 1 J]. Amm Intern Med, 1988, 108(3): 387-389; Fukuda K, Straus SE, Hickie I, et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Difinition and Study. Ann Intern Med, 1994, 121(12): 953-959). CFS is more likely to happen in people at the age group of 20-50 years old, and more common in women. CFS significantly affects work and living of a subject and gains great concern in the medical field.

There are many causes which may lead to fatigue, such as working environment, diet habit and lifestyle, especially the diseases, which may bring to a subject mental stress, physical exertion, and lowered resistance in various functions of the body; as well as the physical exertion caused by drugs, which is easy to lead to fatigue. For example, the symptom of fatigue is normally seen in a cancer or mental patient who is subjected to a treatment.

Currently, the widely used methods of relieving fatigue adjust the body function by sleep and recuperation etc. On the other hand, the body function can be improved by recuperating with external materials. However, there is no anti-fatigue medicament or food with significant effect available in the current market.

Lycium chinense, which is ripe fruit of a deciduous small shrub of Lycium plants in Solanaceae family, is a traditional Chinese herb medicine having effects of strengthening with tonics, replenishing vital essence, dispelling rheumatism, invigorating Yang, strengthening muscles and bones etc. It is recorded in an ancient Chinese medical book named Dietetic Materia Medica that, ripe fruits of Lycium chinense have the functions of "strengthening muscles to endure hard work, dispelling rheumatism, nourishing and benefiting muscles and bones, benefiting human body, and removing asthenic disease". Research of modern pharmacology proves that, the active ingredient of Lycium chinense fruits is lycium barbarum polysaccharide which has the functions of reducing the level of blood sugar and blood fat, improving immunity, antioxidation and anti-fatigue etc. At present, there are literatures reporting the anti-fatigue effect of Lycium chinense fruits as follows:

• LUO Qiong et al. reports the influence of lycium barbarum polysaccharide on the anti-fatigue effect of mice, experiments show that lycium barbarum polysaccharide is the main ingredient for anti-fatigue effect of Lycium chinense fruits (LUO Qiong, YAN Jun and ZHANG Shenghua. Influence of Lycium Barbarum Polysaccharide on the Anti-fatigue Effect for Mice. Journal of Hubei Medical University, 1999, No. 4); WANG Yanwu et al. reports that lycium barbarum polysaccharide has anti-fatigue effect (WANG Yanwu, FU Weizhong, TAN Zongyan et al.. Experimental Research on Anti-fatigue Effect of Lycium Barbarum Polysaccharide. China Tropical Medicine, 2006, No. 8, August 2006,(6):8); PAN Jingyi et al. reports that Lycium chinense fruits has functions of anti-fatigue, improving exercise tolerance and immunity for mice (Experimental Research on Anti-fatigue and Improving Immunity Effects of Lycium chinense Fruits, Shanghai Journal of Preventive Medicine, 2003, Vol. 15, No.8).

Protopanaxadiol is aglycon of ginsenoside diol set, including 20(S)-protopanaxadiol and 20(R)-protopanaxadiol, which are enantiomers to each other and are represented by the following formulas.

20(S)-protopanaxadiol, which does not occur naturally, is a metabolite of ginsenoside in the body. Chinese Patent Application No. CN200610027507.1 discloses the anti-depression activity of 20(S)-protopanaxadiol; Chinese Patent Application No. CN200610027508.6 discloses the anti-intestinal cancer activity of 20(S)-protopanaxadiol; Chinese Patent Application No. CN200610131959.4 discloses novel use of ginsenoside Rh2 for anti-fatigue; Chinese Patent Application No. CN200610017063.3 discloses anti-fatigue effect of a composition comprising ginseng, coffee and tea. The single use of 20(S)-protopanaxadiol for anti-fatigue has not been reported yet.

Although lycium barbarum polysaccharide has a certain anti-fatigue effect, such effect needs to be improved. Until now, there is no patent or literature reporting a compostion consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide for anti-fatigue ( CN100374135C , CN101756090A ).

Contents of the Invention

The object of the invention is to provide an anti-fatigue composition as defined in the appended claims.

Another object of the invention is to provide of the composition.

The anti-fatigue composition according to the invention consists of 20(S)-protopanaxadiol and lycium barbarum polysaccharide.

In the composition, the weight ratio of the 20(S)-protopanaxadiol and lycium barbarum polysaccharide is 0.01-50 to 60-480.

Preferably in the composition, the weight ratio of the 20(S)-protopanaxadiol and lycium barbarum polysaccharide is 0.01-5 to 120-480.

The invention also describes a formulation comprising the above composition, wherein the formulation consists of the composition and pharmaceutically acceptable excipient, and the formulation may be in form of tablets, pills, capsules, granules or oral solution.

The pharmaceutically acceptable excipient is one or more selected from the group consisting of filler, disintegrating agent, adhesive, lubricant, diluent, sweetener, flavoring agent, coloring agent, emulsifier and suspending agent.

The filler is one or more selected from the group consisting of lactose, sucrose, dextrin, mannitol, sorbitol, microcrystalline cellulose and starch.

The disintegrating agent is selected from the group consisting of microcrystalline cellulose, starch, low substituted hydroxypropyl cellulose and crosslinked polyvinylpyrrolidone.

The adhesive is selected from the group consisting of polyvinylpyrrolidone, starch and ethanol.

The lubricant is selected from the group consisting of magnesium stearate, sodium lauryl sulfate, silica and talc.

The diluent is selected from the group consisting of water, ethanol, propylene glycol and glycerol.

The sweetener is one or more selected from the group consisting of glucose, fructose, sucrose, maltose, starch sugar and lactose.

The instant invention further provides use of the above composition and formulation thereof in the preparation of medicaments and healthcare products for anti-fatigue.

The fatigue may result from various causes.

Preferably the fatigue results from diseases.

More preferably the fatigue results from cancer or depression.

Experiments show that the composition according to the invention which consists of 20(S)-protopanaxadiol and lycium barbarum polysaccharide has a synergistic effect in anti-fatigue.

Specific Mode for Carrying out the Invention

The following Examples are intended to further illustrate the present invention without limiting its scope.

Experimental example 1: Effect of composition consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide on mice burden swimming time

According to the Technical Standards for Testing & Assessment of Health Food issued by the Ministry of Health, P. R. China, function and biochemistry indexes assessment of the mixture of 20(S)-protopanaxadiol and lycium barbarum polysaccharide on the function of relieving physical fatigue is conducted; the detailed method is given as follows: 1. Experimental animals: ICR mice, male, 18-22g, provided by Shanghai Slack laboratory animal Co. Ltd., license number: SCXK (Shanghai) 2007-0005; 2. Experimental drugs: 20(S)-protopanaxadiol: provide by Shanghai Innovative Research Center of Traditional Chinese Medicine, batch number: 20050606-1, purity: 94%; lycium barbarum polysaccharide: provided by Shanghai KangZhou Fungi Extract Co. Ltd., polysaccharide content ≥ 30%. To 20(S)-protopanaxadiol is added a small amount of 0.3% CMC-Na, followed by grinding to form a suspension and diluting with CMC-Na to a desired concentration. Then lycium barbarum polysaccharide is added to the 20(S)-protopanaxadiol suspension to form a composition with a certain concentration. 3. Experimental groups: the mice are randomly divided into 19 groups by weight, 20 mice per each group; the detailed groups are as follows:

• normal (solvent) control
• 20(S)-protopanaxadiol: 0.01 mg/kg
• 20(S)-protopanaxadiol: 0.5 mg/kg
• 20(S)-protopanaxadiol: 1 mg/kg
• lycium barbarum polysaccharide: 120mg/kg
• lycium barbarum polysaccharide: 240mg/kg
• lycium barbarum polysaccharide: 480mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.01 mg/kg + 120mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.01mg/kg + 240mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.01mg/kg + 480mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.5mg/kg + 120mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.5mg/kg + 240mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 0.5mg/kg + 480mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 1 mg/kg + 120mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 1 mg/kg + 240mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 1 mg/kg + 480mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 5 mg/kg + 120mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 5 mg/kg + 240mg/kg
• 20(S)-protopanaxadiol + lycium barbarum polysaccharide: 5 mg/kg + 480mg/kg

4. Experimental method: 0.2ml/10g of drug is administrated by gavage every day; for normal control group, 0.2ml/10g of distilled water is administrated by gavage every day; once a day, 30 days in total. 30 minutes after the last time of administrating drug, the end of the tail of each mouse is loaded with copper wires corresponding to 6% of its body weight, then the mouse is put in a swimming box to swim, the time from start of swimming to death of the mouse is recorded, i.e. the mice burden swimming time; the water depth in the swimming box is 30cm or more, and water temperature is 23+1.0°C. 5. Statistical data processing: t-test is conducted to calculate P value, Jin Zhengjun formula is used to conduct combined medication analysis. 6. Experimental results: Mice burden swimming test is conducted with drug dosages of 0.01-5mg/kg of 20(S)-protopanaxadiol and 120-480mg/kg of lycium barbarum polysaccharide, the results are shown in Table 1:

Groups	Dosage (mg/kg)	Animal number	Animal weight start/finish (g)	Swimming time (s)	Change rate of swimming time (%)
normal control group	solvent	20	21.7/39.3	620±285
20(S)-protopanaxadiol	0.01	20	21.6/39.2	640±275	1.5
20(S)-protopanaxadiol	0.5	20	21.8/38.8	660±268	1.9
20(S)-protopanaxadiol	1	20	21.7/38.7	658±296	2.2
20(S)-protopanaxadiol	5	20	21.8/38.9	640±286	1.5
lycium barbarum polysaccharide	120	20	21.7/39.5	783±189**	26.4
lycium barbarum polysaccharide	240	20	21.8/39.7	794±385**	28.1
lycium barbarum polysaccharide	480	20	21.8/38.8	766±282*	23.5
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+120	20	21.7/39.5	798±235**	28
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+240	20	21.8/39.2	843±283**	40
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+480	20	21.9/38.8	865±298**	42.6
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+120	20	21.8/39.3	853±229**	35.5
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+240	20	21.8/39.1	898±322**	44.8
20(S)-protopanaxadiol + lycium	0.5+480	20	21.8/38.7	923±224**	48.9
barbarum polysaccharide
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+120	20	21.8/39.4	842±252**	35.78
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+240	20	21.9/39.1	993±289**	60.2
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+480	20	21.8/38.3	1063±342**	71.4
20(S)-protopanaxadiol + lycium barbarum polysaccharide	5+120	20	21.7/39.2	875±279**	36.42
20(S)-protopanaxadiol + lycium barbarum polysaccharide	5+240	20	21.9/38.8	1069±243**	62.8
20(S)-protopanaxadiol + lycium barbarum polysaccharide	5+480	20	21.8/39.0	1185±242**	75.1

Note: compared with normal control group, *P<0.05, **P<0.01

The results in Table 1 show that: as compared with normal group, lycium barbarum polysaccharide can prolong the mice burden swimming time at different levels, the composition consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide in a weight ratio of 0.01-5 to 120-480 can prolong the mice burden swimming time at different levels (P<0.01, P<0.05); as compared with the effect of 20(S)-protopanaxadiol or lycium barbarum polysaccharide, the composition consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide in a weight ratio of 0.01-5 to 120-480 can also prolong the mice burden swimming time at different levels (P<0.01, P<0.05).

Conclusion: combined use of 20(S)-protopanaxadiol and lycium barbarum polysaccharide exerts an obvious synergistic effect.

Experimental example 2: Effects of the combined dosage of 20(S)-protopanaxadiol and lycium barbarum polysaccharide on mice burden swimming time

Other than the combined dosage of Experimental example 1, the range of combined dosage is enlarged to conduct multi-batch experiments. The experimental animals, drugs and method are the same as those of Experimental example 1, and the final results are shown in Table 2:

Groups	Dosage (mg/kg)	Swimming time change rate
		(%)
normal control group	solvent	0
20(S)-protopanaxadiol	0.01	1.5
20(S)-protopanaxadiol	0.5	1.9
20(S)-protopanaxadiol	1	2.2
20(S)-protopanaxadiol	3	1.6
20(S)-protopanaxadiol	6.25	1.4
20(S)-protopanaxadiol	12.5	3.4
20(S)-protopanaxadiol	25	6.9
20(S)-protopanaxadiol	50	12.4*
lycium barbarum polysaccharide	10	7.5
lycium barbarum polysaccharide	30	8.1
lycium barbarum polysaccharide	60	10.5
lycium barbarum polysaccharide	120	26.4**
lycium barbarum polysaccharide	240	28.1**
lycium barbarum polysaccharide	480	23.5*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+60	21.3*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+120	28**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+240	40**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.01+480	42.6**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+60	25.5**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+120	35.5**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+240	44.8**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	0.5+480	48.9**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+60	22.6*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+120	35.78**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+240	60.2**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	1+480	71.4**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	3+60	22.8*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	3+120	36.8**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	3+240	38.7**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	6.25+60	17.6*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	6.25+120	22.5*
20(S)-protopanaxadiol + lycium barbarum polysaccharide	6.25+240	32.9**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	12.5+120	26.6**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	25+60	38.1**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	25+120	41.7**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	25+240	50.1**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	25+480	32.9**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	50+60	41.9**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	50+120	42.8**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	50+240	48.1**
20(S)-protopanaxadiol + lycium barbarum polysaccharide	50+480	55.5**

Note: compared with normal control group, *P<0.05, **P<0.01

The results in Table 2 show that: as compared with normal control group, single use of 20(S)-protopanaxadiol has no significant effect on mice swimming time (P>0.05), use of 120-480mg/kg of lycium barbarum polysaccharide alone can prolong mice swimming time at different levels (P<0.05, P<0.01), the composition of 20(S)-protopanaxadiol and lycium barbarum polysaccharide in a weight ratio of 0.01-50 to 60-480 can apparently prolong mice burden swimming time (P<0.01 or P<0.05); as compared with the effect of use of 20(S)-protopanaxadiol or lycium barbarum polysaccharide alone, the effect of combined use of 20(S)-protopanaxadiol and lycium barbarum polysaccharide on mice burden swimming time is bigger than the sum of the effects of single use of the two, that is to say, although 20(S)-protopanaxadiol has no effect on mice burden swimming endurance, combined use of 20(S)-protopanaxadiol and lycium barbarum polysaccharide exerts apparent and unexpected synergistic effect.

Conclusion: combined use of 20(S)-protopanaxadiol and lycium barbarum polysaccharide exerts apparent synergistic effect.

Example 1: Tablets of the anti-fatigue composition

500g of lactose is added to 4g of 20(S)-protopanaxadiol and 2000g of lycium barbarum polysaccharide, followed by mixing uniformly, taking 70% ethanol as adhesive, granulating, drying, and then adding 10g of magnesium stearate and tabletting to obtain tablets.

Example 2: Capsules of the anti-fatigue composition

200g of lactose is added to 8g of 20(S)-protopanaxadiol and 2000g of lycium barbarum polysaccharide, followed by mixing uniformly, taking 70% ethanol as adhesive, granulating and filling in capsule to obtain the capsules.

Example 3: Oral solution of the anti-fatigue composition

100g of Tween-80 is added to 16g of 20(S)-protopanaxadiol and 2000g of lycium barbarum polysaccharide, followed by grinding to form primary emulsion, adding water to a volume of 5000ml to obtain the oral solution.

Industrial applicability

The anti-fatigue composition according to the invention consists of 20(S)-protopanaxadiol and lycium barbarum polysaccharide. The experiments show that the composition can apparently prolong the swimming time of mice with weight loading, i.e. it exerts an obvious synergistic effect in anti-fatigue. In comparison with the effect attained by the single use of lycium barbarum polysaccharide or 20(S)-protopanaxadiol, the combined use of 20(S)-protopanaxadiol and lycium barbarum polysaccharide exerts an obvious synergistic effect. The composition according to the invention can be used in the preparation of anti-fatigue medicaments and healthcare products; it provides a novel method of relieving fatigue and possesses industrial applicability.

Claims (8)

1. An anti-fatigue composition consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide.
2. Use of the composition according to claim 1 in the preparation of medicaments and healthcare products for anti-fatigue.
3. The use according to claim 2, wherein the fatigue results from various causes.
4. The use according to claim 3, wherein the fatigue results from diseases.
5. The use according to claim 4, wherein the fatigue results from cancer or depression.
6. A composition consisting of 20(S)-protopanaxadiol and lycium barbarum polysaccharide for use in the treatment of fatigue
7. A composition according to claim 6 for use in the treatment of fatigue, wherein the fatigue results from diseases.
8. A composition according to claim 6 for use in the treatment of fatigue, wherein the fatigue results from cancer or depression.